He won a Nobel here for AlphaFold. Then he left. - John Jumper

AlphaFold transforms structural biology by predicting protein 3D structures from amino acid sequences with near-atomic accuracy, effectively solving a decades-old scientific bottleneck. By replacing years of labor-intensive experimental work with rapid computational predictions, this technology accelerates drug discovery and mechanistic research. John Jumper, a Nobel Prize laureate and lead developer, emphasizes that AlphaFold functions as a specialized predictive tool rather than a universal model of the cell. Its architecture, evolving through iterative refinement and empirical testing, demonstrates that domain-specific engineering and geometric deep learning are essential for advancing scientific frontiers. Beyond its technical design, AlphaFold provides critical infrastructure for global researchers, as evidenced by its application in Africa to combat prevalent diseases like malaria. This shift from manual crystallization to scalable, AI-driven prediction fundamentally alters how scientists approach biological complexity and therapeutic intervention.